Back
DexCom 10K Form
Buy
66
DXCM
DexCom
Last Price:
$78.60
Seasonality Move:
6.97%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-25 | 10Q | DXCM/DexCom Quarterly |
2023-10-26 | 10Q | DXCM/DexCom Quarterly |
2023-07-27 | 10Q | DXCM/DexCom Quarterly |
2023-04-27 | 10Q | DXCM/DexCom Quarterly |
2022-10-27 | 10Q | DXCM/DexCom Quarterly |
2022-07-28 | 10Q | DXCM/DexCom Quarterly |
Receive DXCM News And Ratings
See the #1 stock for the next 7 days that we like better than DXCM
DXCM Financial Statistics
Sales & Book Value
Annual Sales: | $3.6B |
---|---|
Cash Flow: | $88.3M |
Price / Cash Flow: | 62.12 |
Annual Sales: | $5.07 |
Price / Book: | 15.8 |
Profitability
EPS (TTM): | 1.67000 |
---|---|
Net Income (TTM): | $680.8M |
Gross Margin: | $2.3B |
Return on Equity: | 30.96% |
Return on Assets: | 10.48% |
DexCom Earnings Forecast
Key DexCom Financial Ratios
-
The Gross Profit Margin over the past 19 years for DXCM is 63.19%.
-
The Selling, General & Administrative Expenses for DXCM have been equal to 32.73% of Gross Profit Margin.
-
The Research & Development expenses have been 13.96% of Revenue.
-
The Interest Expense is 3.75% of Operating Income.
-
The Net Earning history of DXCM is 14.95% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 12 years.
DexCom Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | DXCM |
CUSIP: | 252131 |
Website: | dexcom.com |
Debt
Debt-to-Equity Ratio: | 1.23 |
---|---|
Current Ratio: | 2.46 |
Quick Ratio: | 2.03 |
Price-to-Earnings
Trailing P/E Ratio: | 61.57 |
---|---|
Forward P/E Ratio: | 39.52 |